Given the clinical relevance of eEF2K in promoting cancer cell survival and tumour development, and the use of cisplatin as a chemotherapeutic agent for multiple tumour types, we sought to clarify the relationship between the molecular functions of eEF2K and cisplatin-induced DNA damage. The gene discussed is EEF2K; the disease is cancer.